Listen "A Promising Drug for Alzheimer's Disease with William Klein, PhD, and Richard Silverman, PhD"
Episode Synopsis
An experimental drug called NU-9 was invented at Northwestern University by Richard Silverman, PhD. It has been approved for clinical trials for the treatment of ALS and found to improves neuron health in animal models of Alzheimer's disease according to a new Northwestern Medicine study published in PNAS. This discovery is giving scientists hope that the drug could be effective in multiple neurodegenerative diseases by addressing the underlying mechanisms of these diseases. Silverman and Northwestern University Alzheimer disease expert, William Klein, PhD, discuss the potential of NU-9 in this episode.
More episodes of the podcast Breakthroughs
Rewind: Leading Neuroscience Research to Inform Mental Health Treatment with Sachin Patel, MD, PhD
03/11/2025
Rewind: The Role of Dopamine in Habit Formation and Compulsive Behavior with Talia Lerner, PhD
25/08/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.